Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
0.25TWD
29.33 MTWD
528.51 MTWD
67.93 M
About GENOVATE BIOTECHNOLOGY CO. LTD.
Sector
CEO
Chia Chen Chu
Headquarters
Hsinchu
Website
Founded
1993
ISIN
TW0004130000
FIGI
BBG000BCFZ06
Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, and sale of specialty pharmaceutical products. Its product includes antimicrobial agents, anticancer agents, cardiovascular system drugs, alimentary tract and metabolic drugs, dermatologic agents, musculoskeletal drugs, nervous system drugs, respiratory drugs, and urinary system drugs. The company was founded on March 24, 1993 and is headquartered in Hsinchu, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4130 is 24.05 TWD — it has decreased by 0.21% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GENOVATE BIOTECHNOLOGY CO. LTD. stocks are traded under the ticker 4130.
GENOVATE BIOTECHNOLOGY CO. LTD. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
4130 stock is 1.25% volatile and has beta coefficient of 0.32. Check out the list of the most volatile stocks — is GENOVATE BIOTECHNOLOGY CO. LTD. there?
Yes, you can track GENOVATE BIOTECHNOLOGY CO. LTD. financials in yearly and quarterly reports right on TradingView.
4130 stock has fallen by 1.03% compared to the previous week, the month change is a 3.41% fall, over the last year GENOVATE BIOTECHNOLOGY CO. LTD. has showed a 11.09% decrease.
4130 net income for the last quarter is −14.32 M TWD, while the quarter before that showed 16.99 M TWD of net income which accounts for −184.28% change. Track more GENOVATE BIOTECHNOLOGY CO. LTD. financial stats to get the full picture.
Today GENOVATE BIOTECHNOLOGY CO. LTD. has the market capitalization of 2.63 B, it has decreased by 0.21% over the last week.
Yes, 4130 dividends are paid annually. The last dividend per share was 0.17 TWD. As of today, Dividend Yield (TTM)% is 0.73%. Tracking GENOVATE BIOTECHNOLOGY CO. LTD. dividends might help you take more informed decisions.
Like other stocks, 4130 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOVATE BIOTECHNOLOGY CO. LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOVATE BIOTECHNOLOGY CO. LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOVATE BIOTECHNOLOGY CO. LTD. stock shows the strong sell signal. See more of GENOVATE BIOTECHNOLOGY CO. LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOVATE BIOTECHNOLOGY CO. LTD. EBITDA is 63.56 M TWD, and current EBITDA margin is 12.03%. See more stats in GENOVATE BIOTECHNOLOGY CO. LTD. financial statements.